Literature DB >> 2070061

Blunted erythropoietin production and decreased erythropoiesis in early pregnancy.

Y Beguin1, G Lipscei, H Thoumsin, G Fillet.   

Abstract

After decreasing in the first trimester of pregnancy, the total red blood cell mass increases in the second and third trimesters to peak at term at about 120% to 125% of nonpregnant values, but how this is brought about by changes in the rate of erythropoiesis is not known. We evaluated erythropoiesis by measuring serum transferrin receptor (TfR) levels in 406 women during normal pregnancy (N = 317), at delivery (N = 63), or in the early postpartum (N = 27). Despite the presence of the placenta and the frequent occurrence of iron deficiency, TfR levels remained low in the first two trimesters and increased in the third trimester and at delivery. To explain why erythropoiesic activity was relatively low in early pregnancy, we also measured serum immunoreactive erythropoietin (Epo) in relation to the degree of anemia. There was a very strong correlation between serum TfR and Epo levels in the entire group (r = .59, P less than .0001) as well as in each period of pregnancy. Epo levels remained low for the degree of anemia and did not correlate with hematocrit in the first two trimesters, but recovered afterwards. In the early postpartum, Epo production and erythropoiesis were normal. We conclude that: (1) erythropoiesis is decreased in the first part of pregnancy but increases afterwards; and (2) blunted Epo production in early pregnancy could be responsible for that observation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070061

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Fenoterol increases erythropoietin concentrations during tocolysis.

Authors:  C H Gleiter; K H Schreeb; S Goldbach; S Herzog; T Cunze; W Kuhn
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

Review 2.  Erythropoietin: a review.

Authors:  D M Ridley; F Dawkins; E Perlin
Journal:  J Natl Med Assoc       Date:  1994-02       Impact factor: 1.798

3.  Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.

Authors:  G Vreugdenhil; B Manger; C Nieuwenhuizen; R A Feelders; H G van Eijk; A J Swaak
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

Review 4.  Inadequate erythropoietin response to anemia: definition and clinical relevance.

Authors:  G Barosi
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

5.  Serum Erythroferrone During Pregnancy Is Related to Erythropoietin but Does Not Predict the Risk of Anemia.

Authors:  Katherine M Delaney; Ronnie Guillet; Eva K Pressman; Tomas Ganz; Elizabeta Nemeth; Kimberly O O'Brien
Journal:  J Nutr       Date:  2021-07-01       Impact factor: 4.687

6.  Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy.

Authors:  Hans Verstraelen; Joris Delanghe; Kristien Roelens; Stijn Blot; Geert Claeys; Marleen Temmerman
Journal:  BMC Infect Dis       Date:  2005-07-06       Impact factor: 3.090

Review 7.  Safety and benefits of antenatal oral iron supplementation in low-income countries: a review.

Authors:  Martin N Mwangi; Andrew M Prentice; Hans Verhoef
Journal:  Br J Haematol       Date:  2017-03-08       Impact factor: 6.998

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.